Hytacand

Hydrochlorothiazide and Candesartan Cilexetil, the active ingredients in Hytacand, are a combination antihypertensive presented as tablets for oral use. They treat hypertension in adults, often when lifestyle measures and monotherapy are insufficient.

GNH USA supplies Hytacand as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hytacand is a combination antihypertensive indicated for the management of high blood pressure.

- Hypertension: lowers systolic and diastolic blood pressure, helping to reduce the risk of cardiovascular events.

Common Side Effects: - Dizziness or light‑headedness - Headache - Fatigue or weakness - Increased urination - Electrolyte disturbances (e.g., low potassium) - Mild gastrointestinal discomfort

Serious or Rare Side Effects: - Severe dehydration or electrolyte imbalance - Acute kidney injury - Hyperkalemia - Angioedema or severe allergic reaction - Significant drop in blood pressure (hypotension) - Liver function abnormalities

Before initiating therapy, consider the following precautions: - Blood pressure monitoring: ensure adequate control and avoid excessive lowering. - Electrolyte assessment: check potassium and sodium levels regularly. - Renal function: evaluate kidney function, especially in patients with chronic kidney disease. - Elderly patients: start at lower doses and monitor for orthostatic symptoms. - History of angioedema: discontinue if swelling of face, lips, or throat occurs. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Hytacand may interact with several medicines; review patient medication lists carefully.

Major Interactions (Avoid): - Aliskiren in diabetic patients: increased risk of renal impairment. - Potassium‑sparing diuretics or supplements: risk of hyperkalemia. - Lithium: increased lithium levels and toxicity. - ACE inhibitors or other ARBs: additive effect on potassium and renal function. - NSAIDs: may reduce antihypertensive efficacy and impair renal function.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may enhance blood‑pressure lowering effect. - Antidiabetic agents: diuretic‑induced changes in glucose may require dose adjustment. - Antimicrobials such as ciprofloxacin: may increase serum levels of candesartan. - Corticosteroids: may counteract diuretic effect and affect electrolytes.